Andrea Freeman

2.4k total citations · 1 hit paper
15 papers, 1.4k citations indexed

About

Andrea Freeman is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Andrea Freeman has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Andrea Freeman's work include Hematopoietic Stem Cell Transplantation (9 papers), Multiple Myeloma Research and Treatments (8 papers) and Cancer Treatment and Pharmacology (4 papers). Andrea Freeman is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Multiple Myeloma Research and Treatments (8 papers) and Cancer Treatment and Pharmacology (4 papers). Andrea Freeman collaborates with scholars based in United States, United Kingdom and Australia. Andrea Freeman's co-authors include Kenneth C. Anderson, Robert Schlossman, Edie Weller, Deborah Doss, Paul G. Richardson, Teru Hideshima, Faith E. Davies, Jerome B. Zeldis, Constantine S. Mitsiades and Joan J. Ryoo and has published in prestigious journals such as Blood, British Journal of Cancer and Mayo Clinic Proceedings.

In The Last Decade

Andrea Freeman

15 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

2002 630 citations Paul G. Richardson, Robert Schlossman et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea Freeman United States	12	1.1k	787	586	221	220	15	1.4k
Anuj Mahindra United States	17	918 0.9×	703 0.9×	477 0.8×	227 1.0×	116 0.5×	56	1.2k
Pei Lin United States	14	717 0.7×	471 0.6×	512 0.9×	267 1.2×	308 1.4×	25	1.2k
Chirag Acharya United States	14	820 0.8×	583 0.7×	855 1.5×	132 0.6×	344 1.6×	29	1.5k
Heather Oakervee United Kingdom	19	1.2k 1.1×	888 1.1×	639 1.1×	184 0.8×	298 1.4×	42	1.6k
Fredrik Schjesvold Norway	16	1.0k 1.0×	766 1.0×	809 1.4×	121 0.5×	230 1.0×	103	1.4k
Ann Mohrbacher United States	14	943 0.9×	661 0.8×	679 1.2×	254 1.1×	292 1.3×	46	1.5k
Cristina Gasparetto United States	19	776 0.7×	656 0.8×	561 1.0×	138 0.6×	110 0.5×	93	1.1k
Nikolaos Kanellias Greece	21	819 0.8×	710 0.9×	579 1.0×	214 1.0×	137 0.6×	132	1.3k
Dixie‐Lee Esseltine United States	11	1.1k 1.1×	1.2k 1.5×	817 1.4×	285 1.3×	63 0.3×	12	1.8k
Dominik Dytfeld Poland	14	1.0k 1.0×	920 1.2×	652 1.1×	113 0.5×	105 0.5×	75	1.3k

Countries citing papers authored by Andrea Freeman

Since Specialization

Citations

This map shows the geographic impact of Andrea Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Freeman more than expected).

Fields of papers citing papers by Andrea Freeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Freeman. The network helps show where Andrea Freeman may publish in the future.

Co-authorship network of co-authors of Andrea Freeman

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Freeman. A scholar is included among the top collaborators of Andrea Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Freeman. Andrea Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Cooke, Marie, et al.. (2015). Pre‐operative self‐efficacy education vs. usual care for patients undergoing joint replacement surgery: a pilot randomised controlled trial. Scandinavian Journal of Caring Sciences. 30(1). 74–82. 21 indexed citations

Richardson, Paul G., Robert Schlossman, Sundar Jagannath, et al.. (2004). Thalidomide for Patients With Relapsed Multiple Myeloma After High-Dose Chemotherapy and Stem Cell Transplantation: Results of an Open-Label Multicenter Phase 2 Study of Efficacy, Toxicity, and Biological Activity. Mayo Clinic Proceedings. 79(7). 875–882. 96 indexed citations

Alyea, Edwin P., Edie Weller, RL Schlossman, et al.. (2003). Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect. Bone Marrow Transplantation. 32(12). 1145–1151. 53 indexed citations

Richardson, Paul G., Robert Schlossman, Edie Weller, et al.. (2002). Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma. Blood. 100(9). 3063–3067. 630 indexed citations breakdown →

Richardson, PG, RL Schlossman, Teru Hideshima, et al.. (2001). A phase 1 study of oral CC5013, an immunomodulatory thalidomide (Thal) derivative, in patients with relapsed and refractory multiple myeloma (MM).. Blood. 98(11). 77516. 23 indexed citations

Alyea, Edwin P., Edie Weller, Robert Schlossman, et al.. (2001). T-cell–depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect. Blood. 98(4). 934–939. 152 indexed citations

Soiffer, RJ, AS Freedman, Donna Neuberg, et al.. (1998). CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin’s lymphoma. Bone Marrow Transplantation. 21(12). 1177–1181. 32 indexed citations

Webb, Iain J., RJ Soiffer, Cheryl Cohen, et al.. (1997). In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation.. PubMed. 3(5). 267–72. 8 indexed citations

Soiffer, RJ, Peter Mauch, Diane L. Fairclough, et al.. (1997). CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.. PubMed. 3(1). 11–7. 20 indexed citations

10.

Soiffer, Robert J., Diane L. Fairclough, Michael J. Robertson, et al.. (1997). CD6-Depleted Allogeneic Bone Marrow Transplantation for Acute Leukemia in First Complete Remission. Blood. 89(8). 3039–3047. 68 indexed citations

11.

Seiden, Michael V., Robert Schlossman, Janet Andersen, et al.. (1995). Monoclonal Antibody-Purged Bone Marrow Transplantation Therapy for Multiple Myeloma. Leukemia & lymphoma. 17(1-2). 87–93. 24 indexed citations

12.

Baer, J, Andrea Freeman, E.S. Newlands, et al.. (1993). Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells. British Journal of Cancer. 67(6). 1299–1302. 171 indexed citations

13.

Anderson, KC, Janet Andersen, RJ Soiffer, et al.. (1993). Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. Blood. 82(8). 2568–2576. 4 indexed citations

14.

Anderson, KC, Janet Andersen, RJ Soiffer, et al.. (1993). Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. Blood. 82(8). 2568–2576. 82 indexed citations

15.

Higby, Donald J., Clifford A. Brass, C. P. Karakousis, et al.. (1983). High-dose cytoreductive therapy with autologous bone marrow transplantation in advanced malignancies.. PubMed. 67(2). 143–8. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact